New advances in severe adverse drug reactions.
Every new drug has the potential for causing cutaneous adverse drug reactions. Usually the clinical pattern is well known and has been described in association with other drugs; new entities, however, are described frequently. This article reviews several of them.
Revuz
J
J
Department of Dermatology, Henri Mondor Hospital, Créteil, France. jean.revuz@hmn.ap-hop-paris.fr
D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D011379:Prognosis; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy